The microbiome and rheumatic heart disease: current knowledge and future perspectives

References

• Carapetis JR, Beaton A, Cunningham MW, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2(1):1–24.
   Web of Science ®Google Scholar
• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.
   PubMed Web of Science ®Google Scholar
• Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015. N Engl J Med. 2017;377(8):713–722.
   PubMed Web of Science ®Google Scholar
• Rwebembera J, Beaton AZ, de Loizaga SR, et al. The global impact of rheumatic heart disease. Curr Cardiol Rep. 2021;23(11):160.
   PubMed Web of Science ®Google Scholar
• Martin WJ, Steer AC, Smeesters PR, et al. Post-infectious group a streptococcal autoimmune syndromes and the heart. Autoimmun Rev. 2015;14(8):710–725.
   PubMed Web of Science ®Google Scholar
• Beaton A, Okello E, Engelman D, et al. Determining the impact of benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (goal trial): study protocol for a randomized controlled trial. Am Heart J. 2019;215:95–105.
   PubMed Web of Science ®Google Scholar
• Cunningham MW. Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. Int Rev Immunol. 2014;33(4):314–329.
   PubMed Web of Science ®Google Scholar
• Chakravarty SD, Zabriskie JB, Gibofsky A. Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunity. Clin Rheumatol. 2014;33(7):893–901.
   PubMed Web of Science ®Google Scholar
• Passos LS, Nunes MC, Aikawa E. Rheumatic heart valve disease pathophysiology and underlying mechanisms. Front Cardiovasc Med. 2020;7:612716.
   PubMed Web of Science ®Google Scholar
• Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121–141.
   PubMed Web of Science ®Google Scholar
• De Luca F, Shoenfeld Y. The microbiome in autoimmune diseases. Clin Exp Immunol. 2019;195(1):74–85.
   PubMed Web of Science ®Google Scholar
• Haase S, Haghikia A, Wilck N, et al. Impacts of microbiome metabolites on immune regulation and autoimmunity. Immunology. 2018;154(2):230–238.
   PubMed Web of Science ®Google Scholar
• Caminer AC, Haberman R, Scher JU. Human microbiome, infections, and rheumatic disease. Clin Rheumatol. 2017;36(12):2645–2653.
   PubMed Web of Science ®Google Scholar
• Guilherme L, Cury P, Demarchi LM, et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol. 2004;165(5):1583–1591.
   PubMed Web of Science ®Google Scholar
• Soares AC, Passos LS, Sable C, et al. Circulating cytokines predict severity of rheumatic heart disease. Int J Cardiol. 2019;289:107–109.
   PubMed Web of Science ®Google Scholar
• Toor D, Sharma N. T cell subsets: an integral component in pathogenesis of rheumatic heart disease. Immunol Res. 2018;66(1):18–30.
   PubMed Web of Science ®Google Scholar
• Toor D, Vohra H. Immune responsiveness during disease progression from acute rheumatic fever to chronic rheumatic heart disease. Microbes Infect. 2012;14(12):1111–1117.
   PubMed Web of Science ®Google Scholar
• Guilherme L, Kalil J. Rheumatic heart disease: molecules involved in valve tissue inflammation leading to the autoimmune process and anti-S. pyogenes vaccine. Front Immunol. 2013;4:352.
   PubMed Web of Science ®Google Scholar
• Wen Y, Zeng Z, Gui C, et al. Changes in the expression of Th17 cell-associated cytokines in the development of rheumatic heart disease. Cardiovasc Pathol. 2015;24(6):382–387.
   PubMed Web of Science ®Google Scholar
• Bas HD, Baser K, Yavuz E, et al. A shift in the balance of regulatory T and T helper 17 cells in rheumatic heart disease. J Investig Med. 2014;62(1):78–83.
   PubMed Web of Science ®Google Scholar
• Abdallah AM, Abu-Madi M. The genetic control of the rheumatic heart: closing the genotype-phenotype gap. Front Med. 2021;8:611036.
   Web of Science ®Google Scholar
• Gray L-A, D'Antoine HA, Tong SYC, et al. Genome-wide analysis of genetic risk factors for rheumatic heart disease in aboriginal Australians provides support for pathogenic molecular mimicry. J Infect Dis. 2017;216(11):1460–1470.
   PubMed Web of Science ®Google Scholar
• Muhamed B, Parks T, Sliwa K. Genetics of rheumatic fever and rheumatic heart disease. Nat Rev Cardiol. 2020;17(3):145–154.
   PubMed Web of Science ®Google Scholar
• Muhamed B, Shaboodien G, Engel ME. Genetic variants in rheumatic fever and rheumatic heart disease. Am J Med Genet C Semin Med Genet. 2020;184(1):159–177.
   PubMed Web of Science ®Google Scholar
• Poomarimuthu M, Ramasamy T, Govindan R, et al. Association of HLA-DRB1 alleles with rheumatic fever and rheumatic heart disease: a meta-analysis. Immunol Invest. 2022;51(2):221–232.
   PubMed Web of Science ®Google Scholar
• Azevedo PM, Merriman TR, Topless RK, et al. Association study involving polymorphisms in IL-6, IL-1RA, and CTLA4 genes and rheumatic heart disease in New Zealand population of Māori and Pacific ancestry. Cytokine. 2016;85:201–206.
   PubMed Web of Science ®Google Scholar
• Bhatt M, Kumar S, Siddiqui MH, et al. Influence of cytokine gene polymorphism on the risk of rheumatic heart disease–a meta-analysis. Immunol Lett. 2018;194:69–78.
   PubMed Web of Science ®Google Scholar
• Col-Araz N, Pehlivan S, Baspinar O, et al. Role of cytokine gene (IFN-gamma, TNF-alpha, TGFbeta1, IL-6, and IL-10) polymorphisms in pathogenesis of acute rheumatic fever in Turkish children. Eur J Pediatr. 2012;171(7):1103–1108.
   PubMed Web of Science ®Google Scholar
• Col-Araz N, Pehlivan S, Baspinar O, et al. Association of macrophage migration inhibitory factor and mannose-binding lectin-2 gene polymorphisms in acute rheumatic fever. Cardiol Young. 2013;23(4):486–490.
   PubMed Web of Science ®Google Scholar
• Düzgün N, Duman T, Haydardedeoğlu FE, et al. The lack of genetic association of the toll-like receptor 2 (TLR2) Arg753Gln and Arg677Trp polymorphisms with rheumatic heart disease. Clin Rheumatol. 2007;26(6):915–919.
   PubMed Web of Science ®Google Scholar
• Maheshkumar P, Sivakumar E, Sambath S, et al. P138 KIR genotypes that encode activating NK cell receptor repertoire are associated with the sever form of rheumatic heart disease among South Indian population. Hum Immunol. 2017;78:155.
   Web of Science ®Google Scholar
• Messias-Reason IJ, Schafranski MD, Kremsner PG, et al. Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clin Exp Immunol. 2009;157(3):395–399.
   PubMed Web of Science ®Google Scholar
• Poomarimuthu M, Elango S, Soundrapandian S, et al. HLA-G 3′ UTR gene polymorphisms and rheumatic heart disease: a familial study among South Indian population. Pediatr Rheumatol. 2017;15(1):1–7.
   PubMedGoogle Scholar
• Poomarimuthu M, Elango S, Solomon PR, et al. Association of IL17 and IL23R gene polymorphisms with rheumatic heart disease in South Indian population. Immunol Invest. 2018;47(7):754–764.
   PubMed Web of Science ®Google Scholar
• Poomarimuthu M, Elango S, Solomon PR, et al. Lack of association between TNF-alpha, IFN-gamma, IL-10 gene polymorphisms and rheumatic heart disease in South Indian population. Fetal Pediatr Pathol. 2018;37(5):309–318.
   PubMed Web of Science ®Google Scholar
• Sendur SN, Hazirolan T, Aydin B, et al. Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly. Acta Cardiol. 2022;77(4):350–359.
   PubMed Web of Science ®Google Scholar
• Arrieta MC, Stiemsma LT, Amenyogbe N, et al. The intestinal microbiome in early life: health and disease. Front Immunol. 2014;5:427.
   PubMed Web of Science ®Google Scholar
• Bauer H, Horowitz RE, Levenson SM, et al. The response of the lymphatic tissue to the microbial flora. Studies on germfree mice. Am J Pathol. 1963;42(4):471–483.
   PubMed Web of Science ®Google Scholar
• Sommer F, Backhed F. The gut microbiota–masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227–238.
   PubMed Web of Science ®Google Scholar
• Gantois I, Ducatelle R, Pasmans F, et al. Butyrate specifically downregulates salmonella pathogenicity island 1 gene expression. Appl Environ Microbiol. 2006;72(1):946–949.
   PubMed Web of Science ®Google Scholar
• Fukuda S, Toh H, Hase K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469(7331):543–547.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Wu L, Huntington ND, et al. Crosstalk between gut microbiota and innate immunity and its implication in autoimmune diseases. Front Immunol. 2020;11:282.
   PubMed Web of Science ®Google Scholar
• Mu Q, Kirby J, Reilly CM, et al. Leaky gut as a danger signal for autoimmune diseases. Front Immunol. 2017;8:598.
   PubMed Web of Science ®Google Scholar
• Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504(7480):451–455.
   PubMed Web of Science ®Google Scholar
• Braniste V, Al-Asmakh M, Kowal C, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6(263):263ra158.
   PubMed Web of Science ®Google Scholar
• Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461(7268):1282–1286.
   PubMed Web of Science ®Google Scholar
• Waldecker M, Kautenburger T, Daumann H, et al. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the Colon. J Nutr Biochem. 2008;19(9):587–593.
   PubMed Web of Science ®Google Scholar
• An D, Oh SF, Olszak T, et al. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell. 2014;156(1-2):123–133.
   PubMed Web of Science ®Google Scholar
• Brown EM, Kenny DJ, Xavier RJ. Gut microbiota regulation of T cells during inflammation and autoimmunity. Annu Rev Immunol. 2019;37:599–624.
   PubMed Web of Science ®Google Scholar
• Bao Y, Dong C, Ji J, et al. Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases. Clin Rheumatol. 2020;39(9):2523–2528.
   PubMed Web of Science ®Google Scholar
• Kocyigit D, Tokgozoglu L, Gurses KM, et al. Association of dietary and gut microbiota-related metabolites with calcific aortic stenosis. Acta Cardiol. 2021;76(5):544–552.
   PubMed Web of Science ®Google Scholar
• Lerner A, Aminov R, Matthias T. Dysbiosis may trigger autoimmune diseases via inappropriate post-translational modification of host proteins. Front Microbiol. 2016;7:84.
   PubMed Web of Science ®Google Scholar
• Alam C, Bittoun E, Bhagwat D, et al. Effects of a germ-free environment on gut immune regulation and diabetes progression in nonobese diabetic (NOD) mice. Diabetologia. 2011;54(6):1398–1406.
   PubMed Web of Science ®Google Scholar
• Kriegel MA, Sefik E, Hill JA, et al. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A. 2011;108(28):11548–11553.
   PubMed Web of Science ®Google Scholar
• Lee YK, Menezes JS, Umesaki Y, et al. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 2011;108(Suppl 1):4615–4622.
   PubMed Web of Science ®Google Scholar
• Maeda Y, Kurakawa T, Umemoto E, et al. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol. 2016;68(11):2646–2661.
   PubMed Web of Science ®Google Scholar
• Chen J, Wright K, Davis JM, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 2016;8(1):1–14.
   PubMedGoogle Scholar
• Sato K, Takahashi N, Kato T, et al. Aggravation of collagen-induced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system. Sci Rep. 2017;7(1):1–13.
   PubMedGoogle Scholar
• Zhong D, Wu C, Zeng X, et al. The role of gut microbiota in the pathogenesis of rheumatic diseases. Clin Rheumatol. 2018;37(1):25–34.
   PubMed Web of Science ®Google Scholar
• Malin M, Verronen P, Mykkanen H, et al. Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora? Br J Rheumatol. 1996;35(7):689–694.
   PubMedGoogle Scholar
• Tejesvi MV, Arvonen M, Kangas SM, et al. Faecal microbiome in new-onset juvenile idiopathic arthritis. Eur J Clin Microbiol Infect Dis. 2016;35(3):363–370.
   PubMed Web of Science ®Google Scholar
• Lopez P, de Paz B, Rodrıguez-Carrio J, et al. Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Sci Rep. 2016;6:24072.
   PubMed Web of Science ®Google Scholar
• Kinumaki A, Sekizuka T, Hamada H, et al. Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis. Front Microbiol. 2015;6:824.
   PubMed Web of Science ®Google Scholar
• Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63(8):1275–1283.
   PubMed Web of Science ®Google Scholar
• Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105(43):16731–16736.
   PubMed Web of Science ®Google Scholar
• Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13(9):R79.
   PubMed Web of Science ®Google Scholar
• Zechner EL. Inflammatory disease caused by intestinal pathobionts. Curr Opin Microbiol. 2017;35:64–69.
   PubMed Web of Science ®Google Scholar
• Forbes JD, Van Domselaar G, Bernstein CN. The gut microbiota in immune-mediated inflammatory diseases. Front Microbiol. 2016;7:1081.
   PubMed Web of Science ®Google Scholar
• Shi XR, Chen BY, Lin WZ, et al. Microbiota in gut, oral cavity, and mitral valves are associated with rheumatic heart disease. Front Cell Infect Microbiol. 2021;11:643092.
   PubMed Web of Science ®Google Scholar
• Haak BW, Littmann ER, Chaubard JL, et al. Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood. 2018;131(26):2978–2986.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895–905.
   PubMed Web of Science ®Google Scholar
• Martinez-Nava GA, Mendez-Salazar EO, Vazquez-Mellado J, et al. The impact of short-chain fatty acid–producing bacteria of the gut microbiota in hyperuricemia and gout diagnosis. Clin Rheumatol. 2023;42(1):203–214.
   PubMed Web of Science ®Google Scholar
• Scher JU, Littman DR, Abramson SB. Microbiome in inflammatory arthritis and human rheumatic diseases: microbiome in rheumatic diseases. Arthritis Rheumatol. 2016;68(1):35–45.
   PubMed Web of Science ®Google Scholar
• Li M, Liang P, Li Z, et al. Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis. Front Microbiol. 2015;6:692.
   PubMed Web of Science ®Google Scholar